Benefit of repetitive intrathecal triamcinolone acetonide therapy in predominantly spinal multiple sclerosis: prediction by upper spinal cord atrophy
C. Lukas, B. Bellenberg, H.K. Hahn, J. Rexilius, R. Drescher, K. Hellwig, O. Köster, S. Schimrigk, Therapeutic Advances in Neurological Disorders 2 (2009) 349–355.